Biomarker Discovery Methodology

Almac Diagnostics use a distinct method to discover Biomarkers.

Biomarker Discovery Methodology

Biomarker is trained against one pre-determined clinical endpoint, meaning only one question can be answered.

 

 

 

Biomarker Discovery Methodology

Almac Biomarkers are discovered using an unsupervised approach which enables assay development based on distinct molecular subgroups, providing the following benefits:

  1. Can have multiple utilities
  2. Functions across multiple diseases
  3. Can migrate to multiple platforms

 

 

Find out more about our Biomarker Discovery here.